Evidence map›Paper›PMID 30555119›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Fatal Invasive Pulmonary Aspergillosis Associated with Nonspecific Interstitial Pneumonia: An Autopsy Case Report.

Hisayo Matsuyama, Shion Miyoshi, Keishi Sugino, Hiroki Ota, Yukitoshi Toyoda, Yasuhiro Nihonyanagi, Kazutoshi Shibuya, Sakae Homma

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hisayo MatsuyamaDepartment of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Shion MiyoshiDepartment of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Keishi SuginoDepartment of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Hiroki OtaDepartment of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Yukitoshi ToyodaDepartment of Emergency and Critical Care Medicine, Toho University Omori Medical Center, Japan.
Yasuhiro NihonyanagiDepartment of Pathology, Toho University Omori Medical Center, Japan.
Kazutoshi ShibuyaDepartment of Pathology, Toho University Omori Medical Center, Japan.
Sakae HommaDepartment of Respiratory Medicine, Toho University Omori Medical Center, Japan.
Toho University · JPToho University Omori Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive pulmonary aspergillosis (IPA) usually occurs in patients with severe immunodeficiencies involving neutropenia. Underlying lung disease is a well-known risk factor of IPA; however, interstitial lung disease has not been recognized as a risk factor of IPA. We herein report a patient with fibrotic nonspecific interstitial pneumonia who experienced IPA without neutropenia. His IPA was fatal and showed unusually slow disease progression over one month. The computed tomography findings showed only nonspecific consolidation and no typical lesions suggestive of IPA. Finally, the autoptic findings revealed numerous Aspergillus fungi, neutrophilic pulmonary necrosis, and vessels invaded by Aspergillus fungi.

Indexed as

AgedAutopsyFatal OutcomeHumansInvasive Pulmonary AspergillosisLung Diseases, InterstitialMaleNeutropeniaRisk FactorsTomography, X-Ray Computedautopsycyclosporine Aimmunocompetentinvasive pulmonary aspergillosisnonspecific interstitial pneumoniaprednisolone

Identifiers

PMID30555119
PMCPMC6355419
OpenAlexW2905124323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.